KRSA
Korsana Biosciences
$30.22
+$0.11 (+0.37%)Oct 29, 2026
Key metrics
The numbers that frame KRSA today
- Market cap
- $20.21M
- Gross margin
- 100%
- EV / Sales
- 9.9
- ROIC
- -145.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $7.19
- 52wk High
- $59.36
Growth
Revenue and earnings trend for KRSA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KRSA
Is Korsana Biosciences a good buy?
Hold. Korsana Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Korsana Biosciences is selling at a very high price.
What is the market capitalization of KRSA?
Korsana Biosciences's market capitalization is $20.21M.
What is the 52-week high for KRSA stock?
The 52-week high for Korsana Biosciences is $59.36. The current close of $30.22 is 49.1% below that high.
What is the 52-week low for KRSA stock?
The 52-week low for Korsana Biosciences is $7.19. The current close of $30.22 is 320.5% above that low.
Does KRSA stock pay dividends?
Korsana Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KRSA?
Korsana Biosciences's Debt / Equity ratio is 0.